Patent ID: 8822144
Filing Date: 2014-09-02
Classification: A61P,C12N,C12Q

Abstract:
1. A method for distinguishing between primary prostate cancer and prostate metastases in a subject with prostate cancer and determining a prognosis and a therapeutic strategy for the subject with prostate cancer based on the distinction between primary prostate cancer and prostate metastases, comprising: (a) providing a biological sample from the subject; (b) determining the expression level of SEQ ID NO: 1 in said sample; (c) comparing said expression level to a threshold expression level, wherein an altered expression level of SEQ ID NO: 1 compared to said threshold expression level allows the distinction between primary prostate cancer and prostate metastases; and (d) determining the prognosis and therapeutic strategy for said subject based on the distinction between primary prostate cancer and prostate metastases.